| [1] |
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci,2004,101(9):2999-3004.
|
| [2] |
Qi L, Bart J, Tan LP, et al. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma[J]. BMC Cancer,2009,9:163.
|
| [3] |
Si ML, Zhu S, Wu H, et al. miR-21-mediated tumor growth[J]. Oncogene,2007,26(19):2799-2803.
|
| [4] |
Frankel LB, Christoffersen NR, Jacobsen A, et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells[J]. J Biol Chem,2008,283(2):1026-1033.
|
| [5] |
Yan LX, Huang XF,Shao Q,et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis[J]. RNA,2008,14(11):2348-2360.
|
| [6] |
Bourguignon LY, Spevak CC, Wong G, et al. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells[J]. J Biol Chem,2009,284(39):26 533-26 546.
|
| [7] |
Chen GQ, Zhao ZW, Zhou HY, et al. Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin[J]. Med Oncol,2010,27(2):406-415.
|
| [8] |
Mei M, Ren Y, Zhou X, et al. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells[J]. Technol Cancer Res Treat,2010,9(1):77-86.
|
| [9] |
Kong W, He L, Coppola M, et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer [J]. J Biol Chem,2010,285(23):17 869-17 879.
|
| [10] |
Jiang S, Zhang HW, Lu MH, et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene [J]. Cancer Res,2010,70(8):3119-3127.
|
| [11] |
Jiang S, Zhang HW, Lu MH, et al.MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene[J]. Cancer Res,2010,70(8),3119-3172.
|
| [12] |
Kong W, Yang H, He L, et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA[J]. Mol Cell Biol,2008,28(22):6773-6784.
|
| [13] |
Johnson CD, Esquela Kerscher A, Stefani G, et al. The let-7 microRNA represses cell proliferation pathways in human cells [J]. Cancer Res,2007,67(16):7713-7722.
|
| [14] |
Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene[J]. Genes Dev,2007,21(9):1025-1030.
|
| [15] |
Dangi Garimella S, Yun J, Eves EM, et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7[J]. EMBO,2009,28(4):347-358.
|
| [16] |
Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer [J]. Cancer Res,2005,65(16):7065-7070.
|
| [17] |
Zhao Y, Deng C, Wang J, et al. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer[J]. Breast Cancer Res Treat,2011,127(1):69-80.
|
| [18] |
Salter KH, Acharya CR, Walters KS, et al. An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer[J]. PLoS One,2008,3(4):1-8.
|
| [19] |
Yang, N, Kaur, S, Volinia, S, et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer[J].Cancer Res,2008,68(24):10307-10314.
|
| [20] |
Cloonan N, Brown MK, Steptoe AL, et al. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition[J]. Genome Biol,2008,9(8):R127.
|
| [21] |
Yu Z, Wang C, Wang M, et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation [J].Cell Biol,2008,182(3):509-517.
|
| [22] |
Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA[J].Mol Cell Biol,2006,26(21):8191-8201.
|
| [23] |
Fontana L, Fiori ME, Albini S, et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM [J]. PLoS ONE,2008,3(5):e2236.
|
| [24] |
Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 [J]. Nat Cell Biol,2008,10(5):593-601.
|
| [25] |
Hurteau GJ,Carlson JA,Spivack SD,et al. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin [J]. Cancer Res,2007,67(17):7972-7976.
|
| [26] |
Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells [J]. EMBO Rep,2008,9(6):582-589.
|
| [27] |
Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis[J]. Cell,2009,137(6):1032-1046.
|
| [28] |
Valastyan S, Benaich N, Chang A, et al. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis [J].Genes Dev,2009,23(22):2592-2597.
|
| [29] |
Ma L, Teruya FJ, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J].Nature,2007,449(7163):682-688.
|
| [30] |
Moriarty CH, Pursell B, Mercurio AM. MiR-10b targets Tiam1: implications for Rac activation and carcinoma migration[J]. J Biol Chem,2010,285(27):20541-20546.
|
| [31] |
Ma L, Reinhardt F, Pan E, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model[J].Nat Biotechnol,2010,28(4):341-347.
|
| [32] |
Gee HE,Camps C,Buffa FM,et al. MicroRNA-10b and breast cancer metastasis [J]. Natu re,2008,455(7216):E8-E9.
|